Newborn Screening Software Market Report 2019 – 2026, Sales Volume, Revenue, Growth Trend and Estimation Forecast

Newborn Screening Software by Test type (Anomaly (CCHD), Physical Examination, Urine Test and Others), by technology(Tandem Mass Spectrometry, DNA Assays, Pulse Oximetry, Enzyme Based Assays and Electrophoresis), By Application (Control and Monitoring, Data Management, Overall Management of Newborn Screening Program and Decision Support), By Region (North America, Europe, APAC and Rest of the World)

  • Report ID : MD1262
  • |
  • Pages : 220
  • |
  • Tables : 85
  • |
  • Formats :

Newborn Screening Software Market revenue shall reach a value of USD Billion in 2025, growing with a CAGR of X.X% during the forecast period of 2018 to 2026. In terms of volume sales, the market is anticipated to reach XX Units.

newborn screening software market
Newborn screening refers to the diagnosis of infants just after their birth for the treatment of the conditions that can be treated easily at that stage. The main aim of this diagnosis is to identify if there is any complication or disease the child is suffering from so that it can be treated as soon as possible. As said, precautions are better than cure, nowadays all parents follow newborn screening for the prevention of any disorder in the child so that it can be treated by medicines or dietary adjustments or some other methods. Newborn screening software has made the diagnosis process much easier as it can be controlled easily and makes the management tasks much easier. Further, government authorities have implemented various policies and schemes to increase awareness about the software among common people. Also, the congenital disorders are increasing day by day which is responsible for many disorders and thereby promoting the newborn screening software market size. Further, the presence of a large number of industry players who are constantly trying to add more advanced features to this software is going to help the market greatly.
The factors such as drawbacks of the newborn screening software, unmet needs, less introduction of new products, low acceptance of advanced medical technology in urban areas, lack of skilled professionals for the operation of this software and lack of awareness about the software in rural areas are the major factors hampering the newborn screening software market growth. Apart from this, the significant contributions of industry players in this industry are expected to overcome all the growth restricting factors. Waters and PerkinElmer are highly popular for the newborn baby screening for metallic disorders. 


REGIONAL ANALYSIS


Based on geography, North America has emerged as the dominant region in terms of revenue. The North American newborn screening software market has accounted for a 48% share of the overall revenue generated in the last few years and is expected to grow with a CAGR of 6.7% during the forecast period. The presence of tech-savvy and health-conscious population in this region is going to accelerate the industry growth. Apart from this, the Asia Pacific region is anticipated to experience a tremendous increase in its revenue owing to the stringent government rules and regulations to prevent disabilities in infants. Further, the market in this region is going to grow at a CAGR of 6.6% in the coming years.


SEGMENT ANALYSIS


The newborn screening software market is bifurcated based on test type, technology, and application. Based on the test type, the market has been segmented as an anomaly (CCHD), physical examination, urine test, and others. Major technologies used in developing this software are tandem mass spectrometry, DNA assays, pulse oximetry, enzyme-based assays, and electrophoresis. Also, major application areas of this software are control and monitoring, data management, overall management of newborn screening program and decision support.


NEWBORN SCREENING SOFTWARE COMPANIES


PerkinElmer, Siemens, Astoria Pacific, Masimo, NeoScreen, Bio-Rad, Northgate, Shimadzu, OZ Systems, SCIEX, and OMNI-Lab NBSare the newborn screening software market players that are investing significantly in the market growth. Further, the increasing prevalence of chronic diseases even in infants are encouraging industry players to manufacture more advanced and highly effective newborn screening software. This is helping these industries to maximize profits.


COVERAGE HIGHLIGHTS    


•    Revenue Estimation and Forecast (2018 – 2026)
•    Production Estimation and Forecast (2018 – 2026)
•    Sales/Consumption Volume Estimation and Forecast (2018 – 2026)
•    Breakdown of Revenue by Segments (2018 – 2026)
•    Breakdown of Production by Segments (2018 – 2026)
•    Breakdown of Sales Volume by Segments (2018 – 2026)
•    Gross Margin and Profitability Analysis of Companies
•    Business Trend and Expansion Analysis
•    Import and Export Analysis
•    Regional Analysis and Data Breakdown

SEGMENTAL ANALYSIS


By Test Type Outlook ($Revenue and Unit Sales, 2018-2026)
•    Anomaly (CCHD)
•    Physical Examination
•    Urine Test
•    Others


By Technology Outlook ($Revenue and Unit Sales, 2018-2026)
•    Tandem Mass Spectrometry
•    DNA Assays
•    Pulse Oximetry
•    Enzyme Based Assays
•    Electrophoresis


By ApplicationOutlook ($Revenue and Unit Sales, 2018-2026)
•    Control and Monitoring
•    Data Management  
•    Overall Management of Newborn Screening Program
•    Decision Support


By Regional Outlook ($Revenue and Unit Sales, 2018-2026)
• North America
• Canada
• U.S
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe

•Asia
• China
• India
• Japan
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Africa
• Latin America


NEWBORN SCREENING SOFTWARE COMPANIES:
•    PerkinElmer
•    Siemens
•    Astoria Pacific
•    Masimo
•    NetScreen
•    Bio-Rad
•    Northgate
•    Shimadzu
•    OZ Systems
•    SCIEX
•    OMNI-Lab NBS

CHAPTER 1:    INTRODUCTION

1.1. Research Methodology

1.1.1. Desk Research

1.1.2. Data Synthesis

1.1.3. Data Validation & Market Feedback

1.1.4. Data Sources

CHAPTER 2:    EXECUTIVE SUMMARY

2.1. Global Market Outlook

2.2. Core Insights - Test Type

2.3. Core Insights – Technology

2.4. Core Insights – Application

2.5. Core Insights – Geography

CHAPTER 3:    MARKET OVERVIEW

3.1.  Market Definition and Scope

3.2. Key Forces Shaping the Industry

3.2.1. Bargaining Power of Suppliers

3.2.2. Bargaining Power of Buyers

3.2.3. Threat of Substitutes

3.2.4. Threat of New Entrants

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Supply-side Drivers

3.3.1.2. Demand-side Drivers

3.3.2. Restraints

3.3.3. Opportunities

3.4. Industry Landscape - PESTEL Analysis

3.4.1. Political Landscape

3.4.2. Environmental Landscape

3.4.3. Social Landscape

3.4.4. Technology Landscape

3.4.5. Economic Landscape

CHAPTER 4:    MARKET BACKGROUND

4.1. Industry Value Chain Analysis

4.1.1. Upstream Participants

4.1.2. Downstream participants

4.2. Pricing Analysis and Forecast, 2018-2026

4.2.1. By Type

4.2.2. By Region

CHAPTER 5:  GLOBAL NEWBORN SCREENING SOFTWARE MARKET, BY TEST TYPE

5.1. Overview

5.1.1. Market Volume and Forecast, 2018-2026

5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

5.2. Anomaly (CCHD)

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Volume and Forecast, By Region

5.2.3. Market Revenue (US$ Million) and Forecast, By Region

5.3. Physical Examination

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Volume and Forecast, By Region

5.3.3. Market Revenue (US$ Million) and Forecast, By Region

5.4. Urine Test

5.4.1. Key Market Trends, Growth Factors and Opportunities

5.4.2. Market Volume and Forecast, By Region

5.4.3. Market Revenue (US$ Million) and Forecast, By Region

5.5. Others

5.5.1. Key Market Trends, Growth Factors and Opportunities

5.5.2. Market Volume and Forecast, By Region

5.5.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 6:  GLOBAL NEWBORN SCREENING SOFTWARE MARKET, BY TECHNOLOGY

6.1. Overview

6.1.1. Market Volume and Forecast, 2018-2026

6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

6.2. Tandem Mass Spectrometry

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Volume and Forecast, By Region

6.2.3. Market Revenue (US$ Million) and Forecast, By Region

6.3. DNA Assays

6.3.1. Key Market Trends, Growth Factors and Opportunities

6.3.2. Market Volume and Forecast, By Region

6.3.3. Market Revenue (US$ Million) and Forecast, By Region

6.4. Pulse Oximetry

6.4.1. Key Market Trends, Growth Factors and Opportunities

6.4.2. Market Volume and Forecast, By Region

6.4.3. Market Revenue (US$ Million) and Forecast, By Region

6.5. Enzyme Based Assays

6.5.1. Key Market Trends, Growth Factors and Opportunities

6.5.2. Market Volume and Forecast, By Region

6.5.3. Market Revenue (US$ Million) and Forecast, By Region

6.6. Electrophoresis

6.6.1. Key Market Trends, Growth Factors and Opportunities

6.6.2. Market Volume and Forecast, By Region

6.6.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 7:  GLOBAL NEWBORN SCREENING SOFTWARE MARKET, BY APPLICATION

7.1. Overview

7.1.1. Market Volume and Forecast, 2018-2026

7.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

7.2. Control and Monitoring

7.2.1. Key Market Trends, Growth Factors and Opportunities

7.2.2. Market Volume and Forecast, By Region

7.2.3. Market Revenue (US$ Million) and Forecast, By Region

7.3. Data Management

7.3.1. Key Market Trends, Growth Factors and Opportunities

7.3.2. Market Volume and Forecast, By Region

7.3.3. Market Revenue (US$ Million) and Forecast, By Region

7.4. Overall Management of Newborn Screening Program

7.4.1. Key Market Trends, Growth Factors and Opportunities

7.4.2. Market Volume and Forecast, By Region

7.4.3. Market Revenue (US$ Million) and Forecast, By Region

7.5. Decision Support

7.5.1. Key Market Trends, Growth Factors and Opportunities

7.5.2. Market Volume and Forecast, By Region

7.5.3. Market Revenue (US$ Million) and Forecast, By Region        

CHAPTER 8:  GLOBAL NEWBORN SCREENING SOFTWARE MARKET, BY GEOGRAPHY

8.1. Overview

8.2. North America

8.2.1. Key Market Trends, Growth Factors and Opportunities

8.2.2. Market Volume and Forecast, By Test Type

8.2.3. Market Volume and Forecast, By Technology

8.2.4. Market Volume and Forecast, By Application

8.2.5. Market Revenue and Forecast, By Test Type

8.2.6. Market Revenue and Forecast, By Technology

8.2.7. Market Revenue and Forecast, By Application

8.2.8. Market Revenue and Forecast, By Country

8.2.9. U.S.

8.2.9.1. Market Volume and Forecast

8.2.9.2. Market Revenue and Forecast

8.2.10. Canada

8.2.10.1. Market Volume and Forecast

8.2.10.2. Market Revenue and Forecast

8.2.11. Mexico

8.2.11.1. Market Volume and Forecast

8.2.11.2. Market Revenue and Forecast

8.3. Europe

8.3.1. Market Volume and Forecast, By Test Type

8.3.2. Market Volume and Forecast, By Technology

8.3.3. Market Volume and Forecast, By Application

8.3.4. Market Revenue and Forecast, By Test Type

8.3.5. Market Revenue and Forecast, By Technology

8.3.6. Market Revenue and Forecast, By Application

8.3.7. Market Revenue and Forecast, By Country

8.3.8. Germany

8.3.8.1. Market Volume and Forecast, By Test Type

8.3.8.2. Market Revenue and Forecast, By Technology

8.3.9. UK

8.3.9.1. Market Volume and Forecast, By Test Type

8.3.9.2. Market Revenue and Forecast, By Technology

8.3.10. France

8.3.10.1. Market Volume and Forecast, By Test Type

8.3.10.2. Market Revenue and Forecast, By Technology

8.3.11. Italy

8.3.11.1. Market Volume and Forecast, By Test Type

8.3.11.2. Market Revenue and Forecast, By Technology

8.3.12. Rest of Europe

8.3.12.1. Market Volume and Forecast, By Test Type

8.3.12.2. Market Revenue and Forecast, By Technology

8.4. Asia-Pacific

8.4.1. Market Volume and Forecast, By Test Type

8.4.2. Market Volume and Forecast, By Technology

8.4.3. Market Volume and Forecast, By Application

8.4.4. Market Revenue and Forecast, By Test Type

8.4.5. Market Revenue and Forecast, By Technology

8.4.6. Market Revenue and Forecast, By Application

8.4.7. Market Revenue and Forecast, By Country

8.4.8. China

8.4.8.1. Market Volume and Forecast, By Test Type

8.4.8.2. Market Revenue and Forecast, By Technology

8.4.9. India

8.4.9.1. Market Volume and Forecast, By Test Type

8.4.9.2. Market Revenue and Forecast, By Technology

8.4.10. Japan

8.4.10.1. Market Volume and Forecast, By Test Type

8.4.10.2. Market Revenue and Forecast, By Technology

8.4.11. South Korea

8.4.11.1. Market Volume and Forecast, By Test Type

8.4.11.2. Market Revenue and Forecast, By Technology

8.4.12. Rest of Asia-Pacific

8.4.12.1. Market Volume and Forecast, By Test Type

8.4.12.2. Market Revenue and Forecast, By Technology

8.5. REST OF THE WORLD

8.5.1. Market Volume and Forecast, By Test Type

8.5.2. Market Volume and Forecast, By Technology

8.5.3. Market Volume and Forecast, By Application

8.5.4. Market Revenue and Forecast, By Test Type

8.5.5. Market Revenue and Forecast, By Technology

8.5.6. Market Revenue and Forecast, By Application

8.5.7. Market Revenue and Forecast, By Country

8.5.8. Latin America

8.5.8.1. Market Volume and Forecast, By Test Type

8.5.8.2. Market Revenue and Forecast, By Technology

8.5.9. Middle East

8.5.9.1. Market Volume and Forecast, By Test Type

8.5.9.2. Market Revenue and Forecast, By Technology

8.5.10. Africa

8.5.10.1. Market Volume and Forecast, By Test Type

8.5.10.2. Market Revenue and Forecast, By Technology

CHAPTER 9:  COMPETITIVE LANDSCAPE

9.1. Newborn Screening Software Market Share Analysis, 2018

CHAPTER 10:    COMPANY PROFILES

10.1. PerkinElmer

10.1.1. Company Overview

10.1.2. Financial Performance

10.1.3. SWOT Analysis

10.2. Siemens

10.2.1. Company Overview

10.2.2. Financial Performance

10.2.3. SWOT Analysis

10.3. Astoria Pacific

10.3.1. Company Overview

10.3.2. Financial Performance

10.3.3. SWOT Analysis

10.4. Masimo

10.4.1. Company Overview

10.4.2. Financial Performance

10.4.3. SWOT Analysis

10.5. NetScreen

10.5.1. Company Overview

10.5.2. Financial Performance

10.5.3. SWOT Analysis

10.6. Bio-Rad

10.6.1. Company Overview

10.6.2. Financial Performance

10.6.3. SWOT Analysis

10.7. Northgate

10.7.1. Company Overview

10.7.2. Financial Performance

10.7.3. SWOT Analysis

10.8. Shimadzu

10.8.1. Company Overview

10.8.2. Financial Performance

10.8.3. SWOT Analysis

10.9. OZ Systems

10.9.1. Company Overview

10.9.2. Financial Performance

10.9.3. SWOT Analysis

10.10. SCIEX

10.10.1. Company Overview

10.10.2. Financial Performance

10.10.3. SWOT Analysis

10.11. OMNI-Lab NBS

10.11.1. Company Overview

10.11.2. Financial Performance

10.11.3. SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com